Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Physical separation of the rectal wall from the prostate gland during radiotherapy" refers to a clinical technique, typically achieved via the transperineal injection of a biocompatible spacer—most commonly a polyethylene glycol (PEG)-based hydrogel—into the anatomical space between the prostate and rectum. The hydrogel temporarily creates distance between these organs, reducing the dose of radiation received by the rectum during prostate radiotherapy, thereby minimizing rectal toxicity without compromising oncologic control of the prostate tumor[1][2][4]. The procedure is image-guided, outpatient, and mainly adopted for patients undergoing external beam or brachytherapy for prostate cancer. This intervention is a **technique** and not a molecular or pharmacologic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Physical separation of rectal wall from prostate gland during radiotherapy.